Time filter

Source Type

Liu G.,Email
Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery

To investigate the clinicopathological features and prognosis of patients with the malignant transformation of sinonasal inverted papilloma. Thirty-two consecutive cases encountered between January 1991 and January 2008 were retrospectively reviewed. Survival rates and prognostic factors were calculated with SPSS 17.0 software using the Kaplan-Meier method and multivariate Cox model survival analysis. The malignancy accounted for 8.99% of all types of sinonasal inverted papilloma. There were 25 males and 7 females, the median age was 56.5 years. The sites of tumor included 22 cases in nasal cavity and ethmoid sinuses, 10 cases in maxillary sinuses. The tumors included 21 high grade tumors, 8 intermediate grade tumors and 3 low grade tumors. Thirty-two patients were staged as T1(3/32), T2(10/32), T3(16/32), T4(3/32). According to the percentage of the malignant cell in the entire tumor tissue, 5 patients were in grade I, 5 patients were in grade II, 8 patients were in grade III, 14 patients were in grade IV. There were 3 distant metastasis in 32 patients; 19 patients underwent surgery plus postoperative radiotherapy, 10 underwent surgery alone and 3 underwent radiotherapy alone. The 5-year overall survival were 72.5%, and the median overall survival time was 62.2 months. Kaplan-Meier univariate survival analysis indicated that the clinical stages and treatment modalities were prognostic factors, and multivariate Cox model survival analysis confirmed that the clinical stages and treatment modalities were independent factors for overall survival (HR were 4.211 and 0.312, all P < 0.05). The morbidity of sinonasal inverted papilloma-associated malignancy is low, the clinical features were not specificity. The clinical stages and treatment modalities may affect the prognosis. Surgery plus postoperative radiotherapy are main treatment means. Source

Liu S.G.,Xinxiang Medical University | Li H.C.,Email
Zhonghua zhong liu za zhi [Chinese journal of oncology]

The aim of this study was to explore the expression of activin A in esophageal squamous cell carcinoma and its clinical significance. Immunohistochemical (IHC) staining was used for detecting the expression of tissue activin A in sixty-four patients with esophageal squamous cell carcinoma, and enzyme-linked immunosorbent assay (ELISA) was used for detecting the serum activin A in the patients before and after surgery. The relationship between expression of activin A in the esophageal cancer tissue with clinicopathological features and its influence on prognosis were analyzed. The positive expression rate of activin A in esophageal squamous cell carcinoma was 82.8% (53/64), and that of normal esophageal epithelium was 6.7% (2/30), showing a very significant difference between them (P < 0.001). Expression of activin A was correlated with both lymph node metastasis and invasion depth of the tumor (all P < 0.05), and the expression of activin A was positively correlated with lymph node metastasis (r = 0.321, P < 0.05) and invasion depth of the tumor (r = 0.417, P < 0.05). The serum activin A of the patients before and after surgery was (911 ± 276) pg/ml and (667 ± 236) pg/ml, respectively, showing a significant difference (P = 0.005). Univariate and multivariate analyses indicated that expression of activin A and lymph node metastasis were independent influencing factors for prognosis in patients with esophageal squamous cell carcinoma (all P < 0.05). Activin A may play an important role in the pathogenesis and development of esophageal squamous cell carcinoma, and it has an important reference value in the estimation of diagnosis and prognosis for esophageal squamous cell carcinoma. Source

Zhao L.,Peking University | Wu Y.,Email
Zhonghua er ke za zhi. Chinese journal of pediatrics

To investigate the characteristics of a new clinical-image syndrome-mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) of corpus callosum. The clinical and imaging features of one pediatric patient with the diagnosis of MERS were analyzed and the clinical and radiologic data of 44 MERS cases which were reported all around the world were also analyzed. The underlying disease of the patient before the onset was respiratory mycoplasma infection. On the second day of the disease course, the patient presented symptoms of encephalopathy. Brain MRI indicated lesions in the splenium of corpus callosum, centrum semiovate and posterior periventricular white matter. And these lesions recovered completely within 3 weeks. Most of the 44 patients diagnosed with MERS were associated with infectious diseases and completely recovered within two weeks. Symptoms included consciousness disturbance, convulsions and dysarthria. In addition to the splenium, brain MRI also showed lesions in genu of corpus callosum, centrum semiovate and white matter of frontal lobe. The clinical presentations of MERS were sudden onset of symptoms of encephalopathy during acute inflammation. Brain MRI indicated a reversible lesion in the splenium of corpus callosum. Patients recover completely within a few days. Source

OBJECTIVE: To prepare the magnetic near infrared fluorescent (NIRF) bifunctional molecular probe with human holo-transferrin (Tf) as a targeted ligand and detect human transferrin receptor (hTfR) actively.METHODS: Molecular probe Tf-cy5.5-IO was prepared and purified by conjugating Tf, superparamagnetic iron oxide (IO) and near infrared fluorescent dye (cy5.5). The particle size and morphology was determined by transmission electron microscopy (TEM), zeta potential and particle sizing analyzer. Human serum albumin (HSA) was used for conjugating with cy5.5 and IO as control. hMSCs and HeLa (as a positive control) were divided into 4 groups: A non-labeled, B Tf-cy5.5-IO, C HSA-cy5.5-IO and D competition assay to confirm the targeted connection. The fluorescent signals from intracellular probe were detected with laser scanning confocal microscope (LSCM) and flow cytometry. Intracellular iron was detected with iron concentration assay and TEM. MRI and NIRF imaging of 2×10(5) cells were performed respectively. Enhancements of R2 value and average intensity (AI) were analyzed qualitatively.RESULTS: The conjugation between IO, Tf and cy5.5 was confirmed with a molar ratio of 1: 2.89: 7.89. The hyperdense aqueous diameter of probe was 23.39 ± 2.42 nm. LSCM showed the fluorescence from Tf-cy5.5-IO and cy3-labeled monoclonal antibody against hTfR in cells and two markers were localized in intracellular compartments of similar appearance. After co-incubating with Tf-cy5.5-IO, the intracellular iron and average intensity were significantly higher than cells of other groups (P < 0.01). MRI and NIRF images showed that, after incubation, intracellular Tf-cy5.5-IO decreased the T2WI signal of human mesenchymal stem cells (hMSCs) and AI on NIRF image increased. Enhancements of R2 value and AI were higher in B group than those in other groups (P < 0.05).CONCLUSION: Tf-cy5.5-IO probe can recognize and conjugate with hTfR specifically. And targeted imaging in vitro of hTfR expressed in hMSCs may be performed by MRI and NIRF multimodal imaging. Source

To investigate the characteristics of menopause of Chinese women with the age of 40-60 years concerning gynecologic clinics in China. From Mar.2008 to Sept.2008, a face-to-face questionnaire was conducted in gynecological clinic in perimenopausal and postmenopausal women in 14 hospitals in China, which included general demographic data, menstrual change process, climacteric symptoms and knowledge about menopause. Modified Kupperman index were used to evaluate climacteric symptoms during the recent week and awareness of hormonal replacement therapy were studied. A total of 1641 women were investigated. The ages of onset of menopause transition, climacteric symptoms and natural menopause were (47 ± 4), (46 ± 4), (49 ± 3) years old respectively. Climacteric symptoms could be found in 78.43% (1287/1641) women during menopausal transition, which were mainly mild to moderate symptoms. The top 5 symptoms were fatigue and weakness (71.48%, 1173/1641), irritability (68.68%, 1127/1641), insomnia (67.65%, 1110/1641), muscle and joint pain (64.11%, 1052/1641) and hot flush (57.90%, 950/1641). The climacteric symptoms were not constant during menopausal transition, usually more severe in late transition and postmenopausal periods, during which the moderate and severe symptoms were 59.1% (189/320) and 51.1% (291/570) respectively. Although most symptoms primarily appeared along with menstruation change, there are about 17.5% (172/981) patients experienced climacteric symptoms before menstruation change occurrence. There were 56.39% (733/1300) women had ever heard (mostly from gynecologist) about hormone replacement therapy from Obstetrician and Gynecologist. Most of the women during menopausal transition had climacteric symptoms, usually mild and moderate ones. Although most symptoms primarily appeared along with menstruation change, there are other patients' experienced climacteric symptoms before menstruation change occurrence. Source

Discover hidden collaborations